标准普尔/澳交所200指数周五收于8774点，上涨0.3%，弥补了前一交易日的一些损失，因为对国内货币政策的鸽派押注支撑了股市。8月就业报告弱于预期，显示就业人数意外下降，强化了今年晚些时候澳大利亚央行降息的预期。大多数分析师预计，9月利率将保持不变，11月可能降息，具体取决于10月公布的第三季度通胀数据。央行表示，在衡量货币宽松步伐时，将依赖季度数据，认为月度数据不太可靠。市场也在等待下周的PMI数据来衡量该国的经济健康状况。在企业新闻方面，Telix Pharmaceuticals飙升6.4%，在花旗银行以“买入”评级开始报道后，领涨医疗保健板块。此外，受华尔街创纪录收盘的推动，科技股上涨0.9%，而对利率敏感的金融股上涨0.6%，最大的银行澳大利亚联邦银行上涨1.5%。

The S&P/ASX 200 finished 0.3% higher at 8,774 on Friday, recouping some losses from the previous session as dovish bets on domestic monetary policy supported equities. A weaker-than-expected August jobs report, showing a surprise drop in employment, reinforced expectations of an RBA rate cut later this year. Most analysts expect rates to remain unchanged in September, with a potential cut in November depending on the Q3 inflation print due in October. The central bank has indicated it will rely on quarterly data, viewing monthly figures as less reliable, as it gauges the pace of monetary easing. Markets also await next week’s PMI figures to gauge the country’s economic health. In corporate news, Telix Pharmaceuticals surged 6.4%, leading healthcare gains after Citi initiated coverage with a “Buy” rating. Additionally, tech stocks jumped 0.9%, boosted by Wall Street’s record closes, while rate-sensitive financials added 0.6%, with top lender Commonwealth Bank of Australia up 1.5%.